Objective: Whereas most septic patients have an underlying comorbidity, most animal models of sepsis use mice that were healthy before the onset of infection. Malignancy is the most common comorbidity associated with sepsis. The purpose of this study was to determine whether mice with cancer have a different response to sepsis than healthy animals.
S epsis affects Ͼ750,000 people in the US annually and is a leading cause of death in critically ill patients (1) . Because most patients who have sepsis have one or more preexisting comorbidities, sep-sis should not be considered a disease that strikes randomly, but instead one that most commonly affects patients who already have some type of chronic illness (1) .
Multiple chronic comorbidities increase mortality in patients with sepsis and in experimental models of the disease (1) (2) (3) (4) . Of these, cancer represents the most common comorbidity in septic patients. Cancer is also the comorbidity associated with the highest risk of death in sepsis, with mortalities of 37% in patients with nonmetastatic disease and 43% in patients with metastatic disease (1, 5) . Of note, cancer patients are nearly 10-times more likely to have sepsis than patients without malignancy (6) . The etiology behind the increased mortality seen in cancer patients who have sepsis compared to healthy patients who have sepsis appears to be multifactorial (6, 7) . Reasons include impaired leukocyte function sec-ondary to the underlying malignancy itself and immunosuppression secondary to cancer treatment (chemotherapy, radiation therapy, immune modulators). Additionally, patients with cancer are prone to having additional chronic comorbid conditions. Among all cancer patients, those with pancreatic cancer have the highest incidence of sepsis, at a rate of Ͼ14,000 cases per 100,000 patients (6) .
There are limited models currently available to understand the interaction between cancer and sepsis. This is because most animal models of sepsis use mice that are healthy before the onset of infection despite the facts that this represents the patient population least likely to have or die of sepsis, and that most patients with sepsis have preexisting comorbidities. It is unclear if healthy mice are appropriate surrogates for patients with preexisting comorbidities. This may be one reason (of many) why positive experimental findings in animal models of sepsis almost never translate into positive clinical trials in patients (8 -11) . To better-understand potential mechanisms responsible for why cancer increases mortality in sepsis, we developed a novel model of pneumonia in mice with cancer.
MATERIALS AND METHODS

Cancer and Sepsis Models
Cancer was induced via injection of the transplantable mouse pancreas adenocarcinoma cell line Pan02 (12) . Pan02 cells were cultured in RPMI-1640 medium supplemented with 10% fetal bovine serum, 1% glutamine, 1% 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, and 1% penicillin/streptomycin (Cellgro, Herndon, VA), and then 250,000 viable cells were injected subcutaneously into the right inner thigh of C57Bl/6 mice (cancer group) (13, 14) . Control animals (healthy group) were handled identically but were injected with an identical volume of phosphatebuffered saline (PBS). Mice were then housed in a barrier facility for 3 wks, during which time nonmetastatic tumors formed in mice injected with Pan02 cells. All mice are from Washington University.
Mice with cancer and healthy mice were then made septic by induction of pneumonia via direct intratracheal injection of Pseudomonas aeruginosa (ATCC 27853) (15, 16) . Under isoflurane anesthesia, a midline cervical incision was made, and 40 L of bacteria diluted in 0.9% NaCl (final concentration, 6 ϫ 10 6 colony-forming units/mL) was introduced into the trachea with a 29-gauge syringe. After incision closure, mice received a 1-mL subcutaneous injection of 0.9% saline to replace insensible fluid losses. Sham mice were treated identically except they were injected with 0.9% saline. This resulted in four groups of animals: healthy sham (PBS followed by 0.9% NaCl), cancer sham (Pan02 followed by 0.9% NaCl), previously healthy septic (PBS followed by Pseudomonas aeruginosa), and cancer septic (Pan02 followed by Pseudomonas aeruginosa). All animals were killed for tissue harvest 24 hrs after intratracheal injection or followed-up for 7-day survival. Mice had free access to food and water and were maintained on a 12-hr light-dark schedule. All studies complied with the National Institutes of Health Guidelines for the Use of Laboratory Animals and were approved by the Washington University Animal Studies Committee.
Lung Histology, Weights, and Apoptosis
Hematoxylin and eosin-stained lung sections were evaluated by a pathologist blinded to sample identity to determine the severity and distribution of pneumonia using a subjective grading scale (17) . Severity grades for each specimen ranged from 0 to 4 (no histopathologic abnormality to most severe pneumonia), whereas distribution grades ranged from 0 to 3 (no abnormality to diffuse pneumonia).
Both lungs were weighed immediately after removal from the body to obtain a "wet" weight. The lungs were then dried overnight at 80°C and reweighed, and a wet-to-dry weight ratio was calculated. Lungs from a different group of animals were stained for active caspase 3 (as described) to quantify pulmonary apoptosis.
Cultures and Cytokine Analysis
The trachea was lavaged with 1 mL of sterile 0.9% NaCl to obtain bronchoalveolar lavage (BAL) fluid. Whole blood was collected retro-orbitally and either processed directly for culture or centrifuged at 5000 rpm for 5 mins. Both BAL and whole blood samples were serially diluted in sterile 0.9% NaCl and plated on blood agar plates. Samples were incubated overnight at 37°C, and colony counts were determined after 24 hrs of incubation. Colony counts were expressed as colony-forming units/mL of fluid and then converted to a logarithmic scale for statistical analysis.
BAL and whole cytokine concentrations were evaluated using a cytometric bead array (BD Mouse Inflammation Kit, San Jose, CA) according to manufacturer protocol. All samples were performed in duplicate.
Complete Blood Counts, Liver Function, and Kidney Function
Blood was obtained retro-orbitally and placed in blood tubes lined with EDTA. Samples were drawn on the same animals 3 days before intratracheal injection of Pseudomonas aeruginosa or 0.9% NaCl and 24 hrs after surgery. Complete blood counts with differentials and quantification of serum aspartate aminotransferase, alanine aminotransferase, blood urea nitrogen, and creatinine were performed by the Division of Comparative Medicine at Washington University.
Intestinal Epithelial Apoptosis
Apoptotic cells in the intestinal epithelium were quantified in 100 contiguous crypt-villus units per animal by hematoxylin and eosinstaining and active caspase-3 staining (18) . Apoptotic cells were identified on hematoxylin and eosin-stained sections by morphologic criteria, in which cells with characteristic nuclear condensation and fragmentation were considered to be apoptotic.
For active caspase-3 staining, sections were deparaffinized, rehydrated, and incubated in 3% hydrogen peroxide for 10 mins. Slides were placed in Antigen Decloaker (Biocare Medical, Concord, CA) and heated in a pressure cooker for 45 mins. Slides were then blocked with 20% goat serum (Vector Laboratories, Burlingame, CA) and incubated with rabbit polyclonal anti-active caspase-3 (1:100; Cell Signaling Technology, Beverly, MA) overnight at 4°C. Sections were incubated with goat anti-rabbit biotinylated secondary antibody (1:200; Vector Laboratories) for 30 mins at room temperature, followed by Vectastain Elite ABC reagent (Vector Laboratories) for 30 mins. Slides were developed with diaminobenzidine and counterstained with hematoxylin.
Intestinal Villus Length and Proliferation
Villus length was measured using Image J software (National Institutes of Health, Bethesda, MD) to measure the distance in m from the crypt neck to the villus tip in 12 well-oriented jejunal villi per animal.
Proliferation was measured in jejunal crypt sections by quantitating the number of Sphase cells in 100 contiguous crypt/villus units. S-phase cells were labeled by injecting mice intraperitoneally with 5-bromo-2Јdeoxyuridine (5 mg/mL; Sigma, St. Louis, MO) 90 mins before killing them (16) . Intestinal sections were then deparaffinized, rehydrated, and incubated in 1% hydrogen peroxide for 15 mins. Antigen retrieval was performed using antigen decloaker with heating in a pressure cooker for 45 mins. Slides were blocked with protein block (Dako, Carpinteria, CA) for 10 mins and incubated with rat monoclonal anti-5-bromo-2Јdeoxyuridine (1:500; Accurate Chemical & Scientific, Westbury, NJ) overnight at 4°C. This was followed by goat antirat secondary antibody (1:500; Accurate Chemical & Scientific) for 30 mins at room temperature. Sections were then placed in streptavidin-horseradish peroxidase (1:500; Dako) for 60 mins at room temperature, developed with diaminobenzidine, and counterstained with hematoxylin.
Splenocyte Apoptosis
Splenocyte apoptosis was quantified via flow cytometry using commercially available antibodies against active caspase-3 (Cell Signaling Technology) and via the TUNEL assay (Apo-5-bromo-2Јdeoxyuridine Kit; Phoenix Flow, San Diego, CA) (19) . T-and B-cell populations were identified using fluoresceinlabeled anti-mouse CD3 (BD Pharmingen, Franklin Lakes, NJ) and PE-Cy5-conjugated anti-mouse CD45R/B220 (eBioscience, San Diego, CA), respectively. Flow cytometric analysis (50,000 events/sample) was per-formed on FACScan (BD Biosciences, San Jose, CA) (20) .
Statistics
Statistical analyses were conducted using Statistical Analysis System version 9.1 (SAS Institute Inc, Cary, NC). Survival studies were analyzed using the log-rank test. Other variables were compared between the study groups using either the two-independentsample Student's t test or the Wilcoxon twosample test, depending on which was appropriate.
Data are presented as mean Ϯ SEM. Nonnormally distributed data are also presented as median and followed by range. A p Ͻ .05 was considered to be statistically significant.
RESULTS
Effect of Cancer on Mortality From Sepsis
Mice with cancer (n ϭ 27) had a higher 7-day mortality than previously healthy mice (n ϭ 29) when subjected to Pseudomonas aeruginosa pneumonia (52% vs. 28%; p ϭ .04, Fig. 1 ). Mice subjected to a sham operation with intratracheal injection of 0.9% NaCl all survived to 7 days regardless of whether they had cancer or were healthy (n ϭ 10; data not shown).
Effect of Cancer in Sham-Operated Animals
Before evaluating potential mechanisms responsible for the mortality difference between septic mice with cancer and septic mice that were previously healthy, it was first necessary to determine what baseline differences existed in these animals independent of Pseudomonas aeruginosa pneumonia. To examine this, mice with cancer given intratracheal injection of 0.9% NaCl 3 wks after injection of Pan02 cells (cancer sham) were compared to mice given intratracheal injection of 0.9% NaCl 3 wks after injection of PBS (healthy sham). All animals were killed 24 hrs after sham operation. Baseline data on all variables examined for septic animals were first evaluated in sham-operated mice. The one exception to this was that cultures were not performed in sham animals because there was no reason to assume sham animals would be actively infected.
No detectable differences were observed between cancer sham and healthy sham mice in body weights, liver func-tion (assayed by aspartate aminotransferase, alanine aminotransferase levels), kidney function (assayed by blood urea nitrogen and creatinine levels), lung histology, wet-to-dry lung ratios, blood cytokine levels (tumor necrosis factor [TNF]-␣, interleukin [IL]-6, IL-10, IL-12, and monocyte chemoattractant protein [MCP]-1), BAL cytokines (IL-6, IL-10, IL-12, and MCP-1), intestinal epithelial apoptosis, intestinal villus length, intestinal proliferation, hematocrit, white blood count, absolute neutrophil count, absolute lymphocyte count, and platelet count (data not shown). However, cancer sham mice had lower levels of T-lymphocyte and B-lymphocyte apoptosis compared to healthy sham mice. Cancer sham mice also had higher levels of TNF-␣ in BAL fluid (Table 1 ) compared to healthy sham mice.
Effect of Cancer on Lungs of Septic Mice
All subsequent experiments compared mice with cancer given intratracheal injection of Pseudomonas aeruginosa 3 wks after subcutaneous injection of Pan02 cells (cancer septic) to healthy mice given intratracheal injection of Pseudomonas aeruginosa 3 wks after subcutaneous injection of PBS (previously healthy septic).
Histologic evaluation of the lungs showed no difference in the severity or distribution of pneumonia between cancer septic and previously healthy septic mice ( Fig. 2A, B) . Wet-to-dry lung weights were also similar in both groups (Fig. 2C ). BAL levels of IL-6 and IL-10 were higher in cancer septic mice than previously healthy mice, whereas no significant differences were found between BAL levels of TNF-␣, IL-12, or MCP-1 ( Table 2 ). Of note, whereas there was a two-fold variation in TNF-␣ levels in sham mice depending on whether an animal had cancer, TNF-␣ levels were Ͼ70fold higher in septic mice independent of whether they had cancer (compare Table  1 to Table 2 ). No differences in pulmonary apoptosis were noted between cancer septic and previously healthy septic mice (n ϭ 8/group; data not shown).
Effect of Cancer on Bacterial Clearance, Body Weights, and Liver and Kidney Function in Septic Mice
Cultures of BAL fluid showed similar levels of Pseudomonas aeruginosa in Figure 1 . Effect of cancer on survival from sepsis. Mice were injected with Pan02 cells (cancer) or phosphate-buffered saline (previously healthy). Three weeks later, all mice were given intratracheal Pseudomonas aeruginosa and then followed-up for 7-day survival. Cancer septic mice had significantly higher mortality than previously healthy mice subjected to the same bacterial insult (p ϭ .04). cancer septic and previously healthy septic mice (5.7 ϫ 10 6 Ϯ 1.7 ϫ 10 6 vs. 3.3 ϫ 10 6 Ϯ 1.5 ϫ 10 6 colony-forming units/ mL; Fig. 3A ). Despite similar levels of local infection, cancer septic mice had increased bacteremia compared to previously healthy septic mice (4.5 ϫ 10 6 Ϯ 1.8 ϫ 10 6 vs. 2.5 ϫ 10 5 Ϯ 1.4 ϫ 10 5 colony-forming units/mL; Fig. 3B ). This was not associated with changes in systemic cytokine levels (Table 2) , body weight ( Fig. 4) , or liver or kidney function (data not shown) between the groups.
Effect of Cancer on White Blood Cell Counts in Septic Mice
Three days before intratracheal injection of Pseudomonas aeruginosa, mice with cancer had a mild increase in absolute neutrophil count compared to healthy mice, although their white blood count and absolute lymphocyte count were similar ( Fig. 5A-C) . Sepsis significantly decreased white blood count, absolute neutrophil count, and absolute lymphocyte count compared to preoperative levels (Fig. 5D-F) . However, these decreases were similar between cancer septic and previously healthy septic mice. Platelet count and hematocrit in septic mice were also unaffected by the presence of cancer (data not shown).
Effect of Cancer on the Intestinal Epithelium in Septic Mice
Intestinal epithelial apoptosis was increased in cancer septic mice compared to previously healthy septic mice by hematoxylin and eosin (11.8 Ϯ 1.4 cells/ 100 crypts vs. 6.5 Ϯ 1.3 cells/100 crypts; Fig. 6A ) and active caspase-3 staining (14.3 Ϯ 2.9 cells/100 crypts vs. 5.8 Ϯ 1.6 cells/100 crypts; Fig. 6B-D) . In contrast, villus length ( Fig. 7A) and crypt proliferation were similar between cancer septic mice and previously healthy septic mice (Fig. 7B ).
Effect of Cancer on Splenic Apoptosis in Septic Mice
Cancer septic mice had decreased levels of T-lymphocyte apoptosis compared to previously healthy septic mice by the TUNEL assay (19.5 Ϯ 4.6% positive cells vs. 9.8 Ϯ 0.5% positive cells; Fig. 8A ) and active caspase-3 staining (16.9 Ϯ 3.2% positive cells vs. 9.8 Ϯ 0.9% positive cells; Fig. 8B ). A similar decrease in B-lympho-cyte apoptosis was noted in cancer septic mice as well by the TUNEL assay (9.9 Ϯ 2.1% positive cells vs. 4.2 Ϯ 0.4% positive cells; Fig. 8C ) and active caspase-3 staining (13.5 Ϯ 2.4% positive cells vs. 6.0 Ϯ 0.5% positive cells; Fig. 8D ). It should be noted that although cancer decreased Tand B-lymphocyte apoptosis compared to that in previously healthy animals in sham mice and septic mice groups, sepsis also independently induced a marked increase in splenocyte apoptosis regardless of whether an animal had cancer (compare Table 1 to Fig. 8 ).
DISCUSSION
Septic patients with cancer are significantly more likely to die than septic pa-tients without cancer. The preexisting pathology seen in a subset of hosts with cancer therefore adversely affects the outcome should the host become septic. Our mouse model of cancer and sepsis, which shows that mice with cancer have significantly higher mortality than previously healthy mice given the identical septic insult, mimics the clinical scenario. The mechanisms underlying this change in mortality may be related to differences in systemic (but not local) bacterial clearance as well as gut epithelial and T-and B-lymphocyte apoptosis. In contrast, the differential mortality between cancer septic and previously healthy septic mice does not grossly appear to be attributable to differences in serum and pulmonary cytokine levels, nutritional intake, liver or kidney function, lung histology, complete blood counts, and intestinal proliferation and length.
This study adds to our understanding of "two-hit" models of critical illness. There are multiple studies published recently in which two physiologic insults that would not be lethal in isolation (such as peritonitis followed by development of pneumonia) combine to cause a disproportionate increase in mortality when the injuries are closely related temporally. Remick (2) recently summarized this phenomenon by stating simply "getting sick when you are already sick is not good." The model of cancer followed by Figure 4 . Effect of cancer on body weights before and after induction of sepsis. Animals were weighed at baseline and were then injected with either Pan02 cells or 0.9% NaCl. Three weeks later, animals were weighed again. Body weights were similar in both groups, regardless of whether they had cancer. Cancer mice and healthy mice were then made septic via intratracheal injection of Pseudomonas aeruginosa and were weighed daily for the next 5 days. All septic mice initially lost weight, but the presence of cancer did not affect body weight after pneumonia. Figure 5 . Effect of cancer on blood counts before and after sepsis. White blood cell count (A) was similar in cancer mice and healthy mice 3 days before induction of Pseudomonas aeruginosa pneumonia. A small increase in absolute neutrophil count (B) was seen in cancer mice (0.03) without a detectable difference in absolute lymphocyte count (C). White blood cell count, absolute neutrophil count, and absolute lymphocyte count were all decreased 24 hrs after the onset of sepsis (D--F); however, levels were unaffected by the presence or absence of cancer. sepsis presented herein can also be thought of as a "two-hit" model. However, instead of the combination of two acute insults, the first "hit" is a chronic comorbidity, whereas the second "hit" is the septic insult. This fits well into the paradigm of "do not get sick when you are sick" (2), because sepsis in the setting of any physiologic perturbation (acute or chronic) appears to result in worse outcomes.
To determine what might account for the difference in mortality seen in septic mice with and without cancer, it is first necessary to determine whether there are baseline differences between cancer mice and healthy mice subjected to a sham operation. The only significant differences noted were that cancer sham mice had lower levels of T-lymphocyte and Blymphocyte apoptosis, as well as higher levels of TNF-␣ in BAL fluid. The fact that there were few detectable differences after sham operation was consistent with the fact that in the absence of sepsis, animals injected with either Pan02 cells or PBS appeared healthy (except for palpable tumors in the former) and grossly had similar levels of activity throughout the study.
Despite the relatively small differences between cancer and healthy mice after sham operation, there was a marked worsening in survival in cancer mice subjected to Pseudomonas aeruginosa pneumonia compared to previously healthy mice subjected to the same insult. This suggests that even though cancer mice do not show large numbers of systemic differences under homeostatic conditions from healthy mice, they do not have the same ability to respond appropriately to a septic insult. This manifests itself in an inability to clear systemic infection. In the Pseudomonas aeruginosa pneumonia model used, infection is introduced locally into the lungs but then spreads systemically into the bloodstream. The concentration of bacteria in the lungs of cancer septic and previously healthy septic mice was similar, and similar to the amount injected 24 hrs earlier. In contrast, there was a nearly 20-fold difference in bacteremia in the animals ( Fig.  3B has been log-transformed). This implies a functional deficit in the immune system of cancer septic mice. Although this was not apparent in the number or differential of white blood cells in the bloodstream, it is likely that leukocytes in cancer septic mice were not as efficient in initiating clearance of bacteria systemi- cally, consistent with preexisting immunosuppression caused by cancer.
Apoptosis has been theorized to play a central role in the pathophysiology of sepsis (21) . Apoptosis in the gut and in lymphocytes is elevated in animal and human autopsy studies of sepsis (22) (23) (24) . Studies in which apoptosis is inhibited in either the intestine or lymphocytes show that prevention of apoptosis in either tissue type improves survival after sepsis (15, (25) (26) (27) (28) . The finding that cancer septic mice have increased intestinal epithelial apoptosis compared to previously healthy mice is consistent with past findings that the combination of an additional insult to sepsis can disproportionately increase gut apoptosis above and beyond what might be expected with either insult in isolation (29, 30) . Although additional studies need to be performed to verify the functional significance of this increased apoptosis, increased sepsisinduced gut epithelial apoptosis may represent a potential mechanism for increased mortality in cancer septic mice.
The T-and B-lymphocyte apoptosis findings under basal conditions and septic conditions were unexpected. First, cancer mice had lower levels of apoptosis in T lymphocytes and B lymphocytes in the spleen than healthy mice when subjected to sham operation. Cancer is frequently associated with alterations in apoptosis in the tumor. Although its effects on lymphocyte apoptosis distant to the tumor are not as well-characterized, it was somewhat surprising that one of only a few detectable effects of Pan02-based tumors in mice that underwent sham operation were that they prevented splenocyte apoptosis distant from the tumor. As has been demonstrated in multiple studies, sepsis induced an increase in splenic apoptosis. This increase was partially independent of cancer because cancer septic and healthy septic mice had a three-to four-fold increase in lymphocyte apoptosis compared to cancer sham and healthy sham mice, respectively. However, lymphocyte apoptosis was markedly lower in cancer septic mice than in previously healthy septic mice. A large body of evidence in the literature suggests that increasing lymphocyte apoptosis is detrimental to the septic host, possibly secondary to immunosuppression (31) . Therefore, it might have been expected that cancer septic mice might have had a further increase in lymphocyte apoptosis (similar to what is seen with gut epithelial apoptosis) compared to previously healthy septic mice. Instead, the exact opposite was seen. The significance of this is unclear. Because the ratio of cancer to previously healthy lymphocyte apoptosis is similar in sham and septic animals, it may be that lymphocyte apoptosis is functionally similar in cancer septic and previously healthy septic mice. If this interpretation is correct, then lymphocyte apoptosis is not responsible for the increased mortality in cancer septic mice. Alternatively, lymphocyte apoptosis may be beneficial in cancer septic mice because lower levels are associated with higher mortality. Theoretically, there might be a threshold of necessary lymphocyte apoptosis in these animals, and levels that are too low may be as detrimental as levels that are too high. Further functional studies are necessary to investigate this unexpected finding.
This study has a number of limitations. The majority of patients with cancer have had the disease for months or years, whereas mice in our model have cancer for 3 wks. Even though there is a 40-fold difference in lifespan between humans and mice, it is possible that the animals have not had time to have chronic changes develop that are seen in patients with cancer. Similarly, cancer develops in patients at a particular anatomical site, whereas a model of injecting pancreatic cancer cells into the thigh of an animal cannot replicate "authentic" pancreatic cancer. Just as the host response can be different based on the inciting organism in sepsis (32-34), cancers of different anatomical origin likely induce different host responses. The tumors induced by Pan02 cells also are not metastatic. Whereas they induce clear loco-regional abnormalities (13, 14) , the basal systemic inflammatory milieu in metastatic disease may cause different effects in sepsis from those seen in nonmetastatic disease. It is therefore unclear how generalizable our results are to sepsis in the setting of other nonpancreaticbased, nonmetastatic cancers, metastatic cancer, or comorbidities other than cancer. Next, the etiology behind differences in mortality between septic patients with cancer and previously healthy septic patients is multifactorial (6, 7) . The studies presented herein do not mimic patients who are at increased risk for sepsis secondary to immunosuppression secondary to treatment for their cancer, such as chemotherapy or radiation therapy. Rather, they are intended to model patients with impaired leukocyte function secondary to the underlying malignancy itself. However, we did not measure a number of elements of functional immunity at baseline that may have shown that cancer mice had detectable chronic immunosuppression before the onset of sepsis. Because all parameters examined except survival were studied solely at 24 hrs, meaningful similarities and differences between cancer septic mice and previously healthy septic mice that occurred at other time points could not be observed.
Despite these limitations, we have demonstrated that cancer independently increases mortality in a murine model of sepsis. This is associated with increased bacteremia, increased intestinal epithelial apoptosis, and decreased splenic apoptosis. Further studies are needed to understand the functional significance of these differences. Performing future studies in animal models more similar to the human disease than currently used models may potentially help translation of preclinical findings into positive clinical trials.
